Bain Capital to acquire Mitsubishi Tanabe Pharma Corporation for $3.3 B

Bain Capital, a leading global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe P...

February 6, 2025 | Thursday | News
Dr. Reddy’s Lab inks oncology deal of $131 M with Shanghai Henlius Biotech

Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of India-based Dr. Reddy’s Laboratories Ltd. has entere...

February 6, 2025 | Thursday | News
BD announces intent to separate biosciences and diagnostic solutions business

BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in the US, has announ...

February 6, 2025 | Thursday | News
ValGenesis and Hitachi join forces to digitally transform Japan’s life sciences sector

US-based ValGenesis Inc., the global leader in enterprise validation lifecycle management systems (VLMS), and Hitachi In...

February 5, 2025 | Wednesday | News
Singapore-based startup Gene Solutions to introduce smart blood test for lung screening in early 2025

Gene Solutions (GS), a pioneer genomic testing company in South-East Asia, aims to introduce a smart blood test to ...

February 5, 2025 | Wednesday | News
MediBuddy partners with Japan's Elecom to launch smart health devices in India

MediBuddy, India's largest digital healthcare company, has announced a strategic partnership with ELECOM, a leading Japa...

February 4, 2025 | Tuesday | News
Alexion Pharmaceuticals Sets New Benchmarks in Rare Disease Innovation and Financial Growth in 2024

  Clinically, Alexion has made substantial strides in the treatment of rare and debilitating conditions. A...

September 4, 2024 | Wednesday | Analysis
Beam Therapeutics Accelerates Progress in Gene-Editing: Major Milestones Achieved in 2024

Beam Therapeutics, a leader in the gene-editing field, continues to make significant progress in its mission to ...

September 4, 2024 | Wednesday | Analysis
Argenx Breaks New Ground in Autoimmune Therapy with 2024 Milestones

Argenx, a global leader in immunology, has made significant strides in 2024, bolstering its position as a pioneer in the...

September 4, 2024 | Wednesday | Analysis
Bluebird Bio Soars: Pioneering Gene Therapies Fuel Rapid Growth in 2024

Bluebird Bio, a pioneering company in the gene therapy sector, has made significant strides in 2024, showcasing both ope...

September 4, 2024 | Wednesday | Analysis
Alnylam Pharmaceuticals Redefines RNAi Therapeutics Leadership with Breakthroughs and Robust Growth in H1 2024

Alnylam Pharmaceuticals achieved significant progress in both its scientific and commercial ...

September 2, 2024 | Monday | Analysis
Novavax Powers Ahead with Breakthrough Vaccines and Strategic Wins in H1 2024

Novavax made significant strides in advancing its vaccine portfolio while solidifying its financial and operatio...

September 2, 2024 | Monday | Analysis
Vertex Pharmaceuticals Redefines Biotech Leadership with Breakthrough Gene Therapies and Record Financial Growth in 2024

Vertex Pharmaceuticals made substantial strides in its therapeutic pipeline, achieved key regulatory approvals, ...

September 2, 2024 | Monday | Analysis
Sarepta Shatters Expectations, Redefines Gene Therapy Leadership with Unprecedented Milestones in 2024's First Half

Sarepta Therapeutics achieved remarkable milestones in gene therapy and muscular dystrophy treatments during the first h...

September 2, 2024 | Monday | Analysis
Regeneron Achieves Breakthroughs in Multiple Therapeutic Areas, Strengthening Leadership in Biotech Innovation

With significant achievements across various therapeutic areas. The company’s progress included robust cli...

September 2, 2024 | Monday | Analysis
Moderna Leads the Charge in Vaccine Innovation and Global Health with Groundbreaking Advances in H1 2024

From January to June 2024, Moderna solidified its position as a leader in biotechnology, making substantial progress acr...

September 2, 2024 | Monday | Analysis
Illumina Drives Transformative Growth with Strategic Divestiture and Cutting-Edge Innovations in H1 2024

From January to June 2024, Illumina demonstrated a dynamic and transformative approach to its business, marking a period...

September 2, 2024 | Monday | Analysis
Gilead Sciences Sets New Standards in HIV Prevention and Oncology with Groundbreaking Clinical Advances in H1 2024

Between January and June 2024, Gilead Sciences made substantial progress across multiple therapeutic areas, reinforcing ...

September 2, 2024 | Monday | Analysis